Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Humbert

Showing results (211-220 of 958) with videos related to

Pageof 96
Sort By:
Medecine Sciences : M/S|October 14, 2021
[Targeting activin receptor IIA ligands for the treatment of pulmonary arterial hypertension]Marc Humbert, David Montani, Laurent Savale, et al.
The European Respiratory Journal|September 11, 2017
Challenging the concept of adding more drugs in pulmonary arterial hypertensionCaio J C Dos Santos Fernandes, Marc Humbert, Rogerio Souza
European Respiratory Review : an Official Journal of the European Respiratory Society|September 3, 2013
Drug-induced pulmonary arterial hypertension: a recent outbreakDavid Montani, Andrei Seferian, Laurent Savale, et al.
Biomolecules|December 24, 2021
Role of Store-Operated Ca<sup>2+</sup> Entry in the Pulmonary Vascular Remodeling Occurring in Pulmonary Arterial HypertensionBastien Masson, David Montani, Marc Humbert, et al.
Annals of Cardiothoracic Surgery|April 18, 2022
Chronic thromboembolic pulmonary hypertension: the magic of pathophysiologyGérald Simonneau, Peter Dorfmüller, Christophe Guignabert, et al.
Journal of Cardiovascular Development and Disease|March 27, 2024
Updated Clinical Classification and Hemodynamic Definitions of Pulmonary Hypertension and Its Clinical ImplicationsMithum Kularatne, Christian Gerges, Mitja Jevnikar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 9, 2021
How to Assess Effectiveness of Biologics for Asthma and What Steps to Take When There Is Not BenefitAmber N Pepper, Nicola A Hanania, Marc Humbert, et al.
Circulation Research|April 26, 2019
Response by Guignabert et al to Letter Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension"Christophe Guignabert, Ly Tu, Jean-Jacques Feige, et al.
Nature Reviews. Cardiology|June 9, 2017
Epidemiology and treatment of pulmonary arterial hypertensionEdmund M T Lau, Eleni Giannoulatou, David S Celermajer, et al.
The European Respiratory Journal|May 2, 2016
Clinical trials: registration and transparencyGiovanni Sotgiu, Marc Humbert, Anh Tuan Dinh-Xuan, et al.
Pageof 96

Showing results (211-220 of 958) with videos related to

Sort By:
Pageof 96
Medecine Sciences : M/S|October 14, 2021
[Targeting activin receptor IIA ligands for the treatment of pulmonary arterial hypertension]Marc Humbert, David Montani, Laurent Savale, et al.
The European Respiratory Journal|September 11, 2017
Challenging the concept of adding more drugs in pulmonary arterial hypertensionCaio J C Dos Santos Fernandes, Marc Humbert, Rogerio Souza
European Respiratory Review : an Official Journal of the European Respiratory Society|September 3, 2013
Drug-induced pulmonary arterial hypertension: a recent outbreakDavid Montani, Andrei Seferian, Laurent Savale, et al.
Biomolecules|December 24, 2021
Role of Store-Operated Ca<sup>2+</sup> Entry in the Pulmonary Vascular Remodeling Occurring in Pulmonary Arterial HypertensionBastien Masson, David Montani, Marc Humbert, et al.
Annals of Cardiothoracic Surgery|April 18, 2022
Chronic thromboembolic pulmonary hypertension: the magic of pathophysiologyGérald Simonneau, Peter Dorfmüller, Christophe Guignabert, et al.
Journal of Cardiovascular Development and Disease|March 27, 2024
Updated Clinical Classification and Hemodynamic Definitions of Pulmonary Hypertension and Its Clinical ImplicationsMithum Kularatne, Christian Gerges, Mitja Jevnikar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 9, 2021
How to Assess Effectiveness of Biologics for Asthma and What Steps to Take When There Is Not BenefitAmber N Pepper, Nicola A Hanania, Marc Humbert, et al.
Circulation Research|April 26, 2019
Response by Guignabert et al to Letter Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension"Christophe Guignabert, Ly Tu, Jean-Jacques Feige, et al.
Nature Reviews. Cardiology|June 9, 2017
Epidemiology and treatment of pulmonary arterial hypertensionEdmund M T Lau, Eleni Giannoulatou, David S Celermajer, et al.
The European Respiratory Journal|May 2, 2016
Clinical trials: registration and transparencyGiovanni Sotgiu, Marc Humbert, Anh Tuan Dinh-Xuan, et al.
Pageof 96